MTF1 and glioblastoma: However, there were no significant changes of MTF1 methylation values in other cancers, such as READ (p = 1.192360E-01), GBM (p = 1.686800E-01), LUSC (p = 2.895400E-01), THCA (p = 4.250800E-01), CHOL (p = 4.342200E-01), STAD (p = 4.353400E-01), pheochromocytoma and paraganglioma (PCPG, p = 6.946400E-01), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC, p = 3.883200E-01), LUAD (p = 4.760400E-01), PAAD (p = 7.941200E-01), THYM (p = 8.679800E-01), esophageal carcinoma (ESCA, p = 9.065400E-01) and sarcoma (SARC, p = 9.610400E-01) (Supplementary Figure S6A-M).